Why the study?
Does extended thromboprophylaxis (28-35 days) with low-molecular-weight heparin reduce venous thromboembolism compared to standard duration (10-14 days) in patients undergoing major orthopaedic surgery?
Does extended thromboprophylaxis (28-35 days) with low-molecular-weight heparin reduce venous thromboembolism compared to standard duration (10-14 days) in patients undergoing major orthopaedic surgery?
Extended thromboprophylaxis (28-35 days) with low-molecular-weight heparin is more effective than standard 10-14 day regimens for preventing VTE after major orthopedic surgery.
May support extended LMWH after major orthopedic surgery; leaves open confirmation with symptomatic VTE endpoints.
The recently reported reductions in the incidence of post-operative venous thromboembolism (VTE) are related to the widespread use of prophylactic anticoagulants. Many uncertainties remain with regard to the most effective ways to use thromboprophylaxis, however. The trend towards shorter hospital stays means that patients may receive less than the recommended 7-10 days of prophylaxis. Prolonged periods of thromboprophylaxis may be beneficial for patients at high risk of post-operative VTE, such as those undergoing major orthopaedic surgery. The relative rarity of symptomatic deep vein thrombosis and pulmonary embolism means that very large patient populations are required for studies that rely on clinical endpoints, but studies using venographic endpoints have shown 28-35 days of prophylaxis with low-molecular-weight heparin to be more effective than 10-14 days. Other factors that may influence the efficacy of thromboprophylaxis include the timing of the first injection and the choice of agent.
No takes yet. Share an insight, caveat, or question.
Hull et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: